These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 19142803)
1. Hepatitis status and mortality in hemodialysis population. Santoro D; Mazzaglia G; Savica V; Li Vecchi M; Bellinghieri G Ren Fail; 2009; 31(1):6-12. PubMed ID: 19142803 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis B and C viruses in pre-dialysis patients with chronic renal failure. Salako BL; Ayodele OE; Kadiri S; Arije A Afr J Med Med Sci; 2002 Dec; 31(4):311-4. PubMed ID: 15027769 [TBL] [Abstract][Full Text] [Related]
3. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083 [TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study. Kalantar-Zadeh K; McAllister CJ; Miller LG Nephrol Dial Transplant; 2005 Aug; 20(8):1662-9. PubMed ID: 15905194 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients. Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen. Selm SB Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1165-8. PubMed ID: 21060200 [TBL] [Abstract][Full Text] [Related]
7. The influence of hepatitis C infection activity on oxidative stress markers and erythropoietin requirement in hemodialysis patients. Tutal E; Sezer S; Ibis A; Bilgic A; Ozdemir N; Aldemir D; Haberal M Transplant Proc; 2010 Jun; 42(5):1629-36. PubMed ID: 20620489 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients. Lezaic V; Stosovic M; Marinkovic J; Rangelov V; Djukanovic L Ren Fail; 2008; 30(1):81-7. PubMed ID: 18197548 [TBL] [Abstract][Full Text] [Related]
9. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study. Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis]. Resić H; Sahović V; Mesić E; Leto E Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861 [TBL] [Abstract][Full Text] [Related]
11. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005. Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735 [TBL] [Abstract][Full Text] [Related]
12. HBV-DNA in hemodialysis patients infected by HCV. Arababadi MK; Hassanshahi G; Yousefi H Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521 [TBL] [Abstract][Full Text] [Related]
14. [The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients]. Motta M; Brischetto R; Rapisarda F; Corno C; Rapisarda C; Fatuzzo P; Messina A; Biondi A; Mezzasalma E; Calcara G Ann Ital Med Int; 1991; 6(4):375-8. PubMed ID: 1666516 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region. Di Napoli A; Pezzotti P; Di Lallo D; Petrosillo N; Trivelloni C; Di Giulio S; Am J Kidney Dis; 2006 Oct; 48(4):629-37. PubMed ID: 16997059 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients. Oyake N; Shimada T; Murakami Y; Ishibashi Y; Satoh H; Suzuki K; Matsumory A; Oda T J Nephrol; 2008; 21(3):345-53. PubMed ID: 18587722 [TBL] [Abstract][Full Text] [Related]
17. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data. Kliem V; Burg M; Haller H; Suwelack B; Abendroth D; Fritsche L; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U Transplant Proc; 2008 May; 40(4):909-14. PubMed ID: 18555076 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and epidemiology of hepatitis C infection in patients on peritoneal dialysis in France. French PD centers. Durand PY; Chanliau J; Gamberoni J; Hestin D; Kessler M Adv Perit Dial; 1996; 12():167-70. PubMed ID: 8865894 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Nieters A; Kallinowski B; Brennan P; Ott M; Maynadié M; Benavente Y; Foretova L; Cocco PL; Staines A; Vornanen M; Whitby D; Boffetta P; Becker N; De Sanjosé S Gastroenterology; 2006 Dec; 131(6):1879-86. PubMed ID: 17087949 [TBL] [Abstract][Full Text] [Related]
20. [Risk factors for hepatitis C in hemodialysis and its impact on the waiting list for kidney transplantation]. Méndez Chacón P; Vidalón A; Vildosola H Rev Gastroenterol Peru; 2005; 25(1):12-8. PubMed ID: 15818418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]